The board of directors exercises authorizations to issue and repurchase C-shares, and converts C-shares to common shares
(WorldNews Sweden)

The annual general meeting of Moberg Pharma AB (publ) on 15 May 2018 resolved - for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programme LTI 2018 resolved by the annual general meeting - to authorize the board of directors to resolve on a directed share issue of no more than 263,000 redeemable- and convertible class C shares. The general meeting also resolved to authorize the board of directors to resolve on the repurchase of all issued class C shares by an offer directed to all holders of class...